| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | G02CB04 |
| UNII: | 80Q9QWN15M |
| InChI Key | GDFGTRDCCWFXTG-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H33N3O3S |
| Molecular Weight | 395.57 |
| AlogP | 2.14 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 72.88 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 27.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Dopamine D2 receptor agonist | BNF |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Ovarian Hyperstimulation Syndrome | 2 | D016471 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 87056-78-8 |
| ChEMBL | CHEMBL2218861 |
| FDA SRS | 80Q9QWN15M |
| PubChem | 22942549 |
| SureChEMBL | SCHEMBL678170 |